The potential biomarker of NPTXR was also validated in the van Steenoven, Koel-Simmelink (2020) [117] study, which reported that the expression of CSF NPTXR was low in PD and even lower in dementia with Lewy bodies. The gene discussed is NPTXR; the disease is dementia.